science bio semaglutide Peptide of the Week: Peptide: A Promising Advancement in Diabetes Treatment Semaglutide GLP-1 Receptor Agonist Research

When it comes to weight loss medications, two names keep popping up: retatrutide and semaglutide

REFERENCES: Kevin Kargman, Semaglutide and Blood Clots: What You Need to Know for Safety and Health, May 29, 2024 Yaqin Zhang, Ruofei Chen, Yangyang Jia, Mingwei Chen, Zongwen Shuai, Effects of Exenatide on Coagulation and Platelet Aggregation in Patients with Type 2 Diabetes, Drug Des Devel Ther 2021 Jul 12;15:30273040 " Ingram, I., GLP-1 Drugs Tied to Reduced Risk of Dangerous Blood Clots, MedPage TodayDecember 8, 2024, ABSTRACT: Patell R "Glucagon-like peptide 1 receptor agonists reduce the risk of venous thromboembolism in patients with diabetes irrespective of obesity: a propensity score-matched multicenter database analysis" ASH 2024

You'll likely notice immediate hydration and a temporary glow after the first use

Counsel patients regarding the potential risk for MTC with the use of Wegovy and inform them of symptoms of thyroid tumors (e.g